Novel Anthranilamide-Based FXa Inhibitors: Drug Design, Synthesis and Biological Evaluation.

about

Spectroscopic, DFT, and XRD Studies of Hydrogen Bonds in N-Unsubstituted 2-Aminobenzamides.Inhibitory Effect of Triterpenoids from Panax ginseng on Coagulation Factor X.

P2860

Q46931993-F2712E2A-0D9A-4BBE-9C0C-A0A1455C1434 Q50702069-427FF096-FFEE-40F6-B993-4F6EC05D57BF

P2860

Novel Anthranilamide-Based FXa Inhibitors: Drug Design, Synthesis and Biological Evaluation.

Item

http://www.wikidata.org/entity/Q51367467

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Novel Anthranilamide-Based FXa ...... sis and Biological Evaluation.

@en

Novel Anthranilamide-Based FXa ...... sis and Biological Evaluation.

@nl

type

Item

label

Novel Anthranilamide-Based FXa ...... sis and Biological Evaluation.

@en

Novel Anthranilamide-Based FXa ...... sis and Biological Evaluation.

@nl

prefLabel

Novel Anthranilamide-Based FXa ...... sis and Biological Evaluation.

@en

Novel Anthranilamide-Based FXa ...... sis and Biological Evaluation.

@nl

P1476

Novel Anthranilamide-Based FXa ...... esis and Biological Evaluation

@en

P2093

Changjiang Huang

http://www.w3.org/2001/XMLSchema#string

Jing Yuan

http://www.w3.org/2001/XMLSchema#string

Shijun Zhang

http://www.w3.org/2001/XMLSchema#string

Weiren Xu

http://www.w3.org/2001/XMLSchema#string

Xiaoli Fu

http://www.w3.org/2001/XMLSchema#string

Yongnan Xu

http://www.w3.org/2001/XMLSchema#string

P2860

Design and quantitative structure-activity relationship of 3-amidinobenzyl-1H-indole-2-carboxamides as potent, nonchiral, and selective inhibitors of blood coagulation factor Xa

Molecular structures of human factor Xa complexed with ketopiperazine inhibitors: preference for a neutral group in the S1 pocket

7-fluoroindazoles as potent and selective inhibitors of factor Xa

Structure-activity relationships of anthranilamide-based factor Xa inhibitors containing piperidinone and pyridinone P4 moieties

Discovery of the novel antithrombotic agent 5-chloro-N-({(5S)-2-oxo-3- [4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene- 2-carboxamide (BAY 59-7939): an oral, direct factor Xa inhibitor

The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Discovery of 1-[3-(aminomethyl)phenyl]-N-3-fluoro-2'-(methylsulfonyl)-[1,1'-biphenyl]-4-yl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide (DPC423), a highly potent, selective, and orally bioavailable inhibitor of blood coagulation factor Xa.

Rivaroxaban in patients with a recent acute coronary syndrome.

Coagulation factor Xa inhibition: biological background and rationale.

Review of atrial fibrillation outcome trials of oral anticoagulant and antiplatelet agents.

P304

491

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/MOLECULES21040491

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Fancui Meng

Wenzhi Wang

P577

2016-04-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27089317

http://www.w3.org/2001/XMLSchema#string

P932

6274369

http://www.w3.org/2001/XMLSchema#string

Novel Anthranilamide-Based FXa Inhibitors: Drug Design, Synthesis and Biological Evaluation.

about

P2860

P2860

Novel Anthranilamide-Based FXa Inhibitors: Drug Design, Synthesis and Biological Evaluation.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932